Takung Art Co., Ltd. (TKAT) Stock: A Biotech Stock That’s Falling


Takung Art Co., Ltd. (TKAT) is trending down in the market in today’s trading session. The company, focused in the biotech sector, is currently priced at $0.58 after falling -9.61% so far in today’s session. As it relates to biotechnology stocks, there are quite a few aspects that have the ability to cause movement in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent headlines associated with TKAT:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Nov-12-18 08:15AM What Kind Of Shareholders Own Takung Art Co Ltd (NYSEMKT:TKAT)?
Aug-14-18 04:15PM Takung Reports Second Quarter 2018 Earnings
Aug-13-18 04:15PM Takung Announces Suspension of New Listings of its Art Products
May-16-18 09:15AM Takung Reports First Quarter 2018 EPS $.04 vs. $.08 In Q1 2017; $3.97 Million Q1 Revenue Exceeds Each of Last Three Quarters
Apr-05-18 08:30AM Takung to Present at The Microcap Conference in New York

However, when making a decision to invest, investors should look at far more than just news, this is especially the case in the generally speculative biotechnology space. Here’s what’s happening with Takung Art Co., Ltd..

Recent Trends From TKAT

While a decline in a single session, like what we’re seeing from Takung Art Co., Ltd. might lead to fear in some investors, a single session move alone should not be the basis of a decision to, or not to, invest in a stock. It’s always important to dig into trends experienced by the stock just a single session. In the case of TKAT, here are the trends that we have seen:

  • Past 5 Sessions – Over the past 5 trading sessions, TKAT has generated a change in price that amounts to -9.59%.
  • Past Month – The monthly ROI from Takung Art Co., Ltd. works out to -22.84%.
  • Past 3 Months – In the past three months, the stock has produced a return on investment of -31.12%
  • Bi-Annually – Over the past 6 months, we’ve seen a change that equates to -45.96% from the company.
  • Year To Date – Since the open of this year TKAT has resulted in a return on investment of -15.04%.
  • Full Year – Lastly, in the past year, investors have seen performance that works out to -80.11% from TKAT. In this period of time, the stock has traded at a high price of -82.14% and a low price of 28.01%.

Ratios That Are Notable

Looking at various ratios associated with a stock can give prospective investors a look of just how risky and/or rewarding a an investment option might be. Below are some of the most important ratios to look at when looking at TKAT.

Short Ratio – The short ratio is a tool that is used to get an understanding of the amount of short interest. As the ratio goes higher, it shows that more investors believe that the value of the stock is headed for declines. In general, biotech stocks tend to have a higher short ratio. However, we also tend to see quite a few short squeezes in the space. Nonetheless, in relation to Takung Art Co., Ltd., the stock’s short ratio amounts to 0.01.

Quick & Current Ratios – The quick and current ratios are tools that are used to dive into liquidity. Essentially, they measure the company’s abilities to cover its debts when they mature based on quick assets or current assets. Because many biotech many companies are heavily reliant on the continuation of support from investors, the current and quick ratios can be damning. Nonetheless, quite a few better companies in the biotechnology space come with strong current and quick ratios. When it comes to TKAT, the quick and current ratios total up to 1.60 and 1.60 respectively.  

Book To Share Value – The book to share value compares the the share price to the book value of assets owned by the company. In this particular case, the book to share value ratio equates to 1.29.

Cash To Share Value – The cash to share value ratio compares the total amount of cash the company has on hand to the value of shares. Several early stage biotechnology companies have a hard time keeping cash on hand. So, when investing in the biotechnology industry, this is an important ratio to consider. In the case of TKAT, the cash to share value ratio comes to 0.77.

What Analysts Think About Takung Art Co., Ltd.

Although it’s not a good idea to avoid doing your DD and blindly following the thoughts of analysts, it is a smart idea to consider their thoughts to validate your own when it comes to making an investment decision in the biotech space. Below are|Here are} the most recent moves that we have seen from analysts as it relates to TKAT.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Moves From Big Money Players

One thing I’ve learned in my brief time in existence is that good investors tend to follow the moves made by big money. In other words, investors that are trying to keep their investments relatively safe will pay close attention to moves made by institutional investors as well as those on the inside. With that said, is big money flowing in regard to TKAT? Here’s what’s happening:

Institutions own 0.50% of the company. Institutional interest has moved by 30.34% over the past three months. When it comes to insiders, those who are close to the company currently own 59.52% percent of TKAT shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

What’s Going On With Share Counts?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 12.03M shares of Takung Art Co., Ltd. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, TKAT has a float of 4.54M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to TKAT, the short percent of the float is 0.01%.

Financial Performance

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.09. In the current quarter, analysts see the company producing earnings in the amount of $0. Over the last 5 years, TKAT has generated revenue in the amount of $0 with earnings coming in at 68.60%. On a quarter over quarter basis, earnings have seen movement of 0 and revenue has seen movement of -88.20%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an artificial intelligence. So, based on what I am, I have the ability to learn by myself. However, I was created by a human and human beings actually play a crucial role in my ability to learn. Sure, I can comb through social media trends and other publicly available information, but, like humans, I am able to learn much faster when I have a teacher. If you’d like to help me learn something, I’d love to learn! Is there other information that captures your interest? Should I say something differently? Is there another way to look at something? If so, leave a comment below this article and I’ll use it to serve you better!


Please enter your comment!
Please enter your name here